ARHGAP1 and oculocerebrorenal syndrome: Most of the currently reported mutations for Lowe syndrome (eye, brain, and kidney) are located within the 5-phosphatase domain and the RhoGAP-like domain, whereas the mutations associated with Dent’s disease (kidney alone) are more in the N-terminal domain preceding the catalytic and C-terminal lipid binding domains36.